Suppr超能文献

正常成年人中,有阿尔茨海默病母系家族史者灰质体积减少。

Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.

机构信息

University of Kansas School of Medicine, Department of Neurology, 2100 West 36th Ave., Suite 110, Kansas City, KS 66160, USA.

出版信息

Neurology. 2010 Jan 12;74(2):113-20. doi: 10.1212/WNL.0b013e3181c918cb.

Abstract

OBJECTIVE

A consistently identified risk factor for Alzheimer disease (AD) is family history of dementia, with maternal transmission significantly more frequent than paternal transmission. A history of maternal AD may be related to AD-like glucose consumption in cognitively healthy subjects. In this cross-sectional study, we tested whether cognitively healthy people with a family history of AD have less gray matter volume (GMV), an endophenotype for late-onset AD, than individuals with no family history, and whether decreases in GMV are different in subjects with a maternal family history.

METHODS

As part of the Kansas University Brain Aging Project, 67 cognitively intact individuals with a maternal history of late-onset AD (FHm, n = 16), a paternal history of AD (FHp, n = 8), or no parental history of AD (FH-, n = 43), similar in age, gender, education, and Mini-Mental State Examination score, were scanned at 3 T. We used voxel-based morphometry to examine GMV differences between groups, controlling for age, gender, and apoE4.

RESULTS

Cognitively healthy individuals with a family history of late-onset AD had significantly decreased GMV in the precuneus, middle frontal, inferior frontal, and superior frontal gyri compared with FH- individuals. FHm subjects had significantly smaller inferior frontal, middle frontal, precuneus, and lingual gyri compared with FH- and FHp subjects.

CONCLUSIONS

Overall, maternal family history of Alzheimer disease (AD) in cognitively normal individuals is associated with lower gray matter volume in AD-vulnerable brain regions. These data complement and extend reports of cerebral metabolic differences in subjects with a maternal family history.

摘要

目的

阿尔茨海默病(AD)的一个明确的危险因素是痴呆家族史,其中母系遗传比父系遗传更为常见。AD 的家族史可能与认知正常的个体中 AD 样葡萄糖消耗有关。在这项横断面研究中,我们测试了是否有 AD 家族史的认知正常个体的灰质体积(GMV)减少,GMV 是迟发性 AD 的一个内表型,其 GMV 减少程度是否与有母系家族史的个体不同。

方法

作为堪萨斯大学大脑老化项目的一部分,67 名认知正常的个体有晚发性 AD 的母系家族史(FHm,n = 16)、父系家族史(FHp,n = 8)或无 AD 家族史(FH-,n = 43),年龄、性别、教育程度和 Mini-Mental State 考试成绩相似,在 3T 下进行扫描。我们使用基于体素的形态测量学来检查组间 GMV 的差异,同时控制年龄、性别和 apoE4。

结果

与 FH-个体相比,有晚发性 AD 家族史的认知正常个体的扣带回、额中回、额下回和额上回的 GMV 明显减少。FHm 个体的额下回、额中回、扣带回和舌回的 GMV 明显小于 FH-和 FHp 个体。

结论

总体而言,认知正常个体的 AD 母系家族史与 AD 易损脑区的 GMV 减少有关。这些数据补充和扩展了母系家族史个体脑代谢差异的报告。

相似文献

1
Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.
Neurology. 2010 Jan 12;74(2):113-20. doi: 10.1212/WNL.0b013e3181c918cb.
2
Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.
Neurology. 2011 Mar 1;76(9):822-9. doi: 10.1212/WNL.0b013e31820e7b74.
3
Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19067-72. doi: 10.1073/pnas.0705036104. Epub 2007 Nov 14.
4
Structural brain changes in normal individuals with a maternal history of Alzheimer's.
Neurobiol Aging. 2011 Dec;32(12):2325.e17-26. doi: 10.1016/j.neurobiolaging.2011.01.001. Epub 2011 Feb 12.
5
Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults.
Arch Gen Psychiatry. 2007 Oct;64(10):1163-71. doi: 10.1001/archpsyc.64.10.1163.
6
Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.
Neurology. 2012 May 29;78(22):1769-76. doi: 10.1212/WNL.0b013e3182583047. Epub 2012 May 16.
7
Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD.
Neurology. 2014 Mar 4;82(9):752-60. doi: 10.1212/WNL.0000000000000181. Epub 2014 Feb 12.
8
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.
Neurology. 2009 Feb 10;72(6):513-20. doi: 10.1212/01.wnl.0000333247.51383.43. Epub 2008 Nov 12.
10
Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults.
Neurobiol Aging. 2016 Feb;38:14-20. doi: 10.1016/j.neurobiolaging.2015.10.018. Epub 2015 Nov 10.

引用本文的文献

1
TOMM40 may mediate GFAP, neurofilament light Protein, pTau181, and brain morphometry in aging.
Aging Brain. 2024 Dec 13;7:100134. doi: 10.1016/j.nbas.2024.100134. eCollection 2025.
3
Visual Impairment, Eye Conditions, and Diagnoses of Neurodegeneration and Dementia.
JAMA Netw Open. 2024 Jul 1;7(7):e2424539. doi: 10.1001/jamanetworkopen.2024.24539.
4
Automated detection of Alzheimer's disease: a multi-modal approach with 3D MRI and amyloid PET.
Sci Rep. 2024 Mar 3;14(1):5210. doi: 10.1038/s41598-024-56001-9.
5
Alzheimer's disease cortical morphological phenotypes are associated with TOMM40'523-APOE haplotypes.
Neurobiol Aging. 2023 Dec;132:131-144. doi: 10.1016/j.neurobiolaging.2023.09.001. Epub 2023 Sep 11.
10

本文引用的文献

1
Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease.
Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):188-97. doi: 10.1097/WAD.0b013e31819cb8a2.
2
The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life.
Neurology. 2009 Sep 1;73(9):665-73. doi: 10.1212/WNL.0b013e3181b01077. Epub 2009 Jul 8.
3
Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study.
J Alzheimers Dis. 2009;18(3):553-64. doi: 10.3233/JAD-2009-1163.
4
Factors associated with resistance to dementia despite high Alzheimer disease pathology.
Neurology. 2009 Jan 27;72(4):354-60. doi: 10.1212/01.wnl.0000341273.18141.64.
6
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.
Neurology. 2009 Feb 10;72(6):513-20. doi: 10.1212/01.wnl.0000333247.51383.43. Epub 2008 Nov 12.
8
Magnetic resonance imaging traits in siblings discordant for Alzheimer disease.
J Neuroimaging. 2008 Jul;18(3):268-75. doi: 10.1111/j.1552-6569.2007.00191.x.
9
Cardiorespiratory fitness and brain atrophy in early Alzheimer disease.
Neurology. 2008 Jul 15;71(3):210-6. doi: 10.1212/01.wnl.0000317094.86209.cb.
10
VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study.
Neurology. 2008 Jun 3;70(23):2201-11. doi: 10.1212/01.wnl.0000303960.01039.43. Epub 2008 Apr 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验